The invention refers to a fully human miniantibody (scFv), called Erbicin, specific for the receptor ErbB2, with a pharmacological, in particular antitumour, activity. It has been obtained from a larger fagmidic library (Griffin 1.) of human synthetic scFv by panning (affinity selection on antigen) carried out on live cells that express various levels of ErbB2. The invention relates also to the DNA and amino acid sequences of said antibody, to the procedure for isolating it, to its use in therapy.
Human mini-antibody cytotoxic for tumor cells which express the ErbB2 receptor / D'Alessio, Giuseppe; Piccoli, Renata; DE LORENZO, Claudia; Palmer, Db; Ritter, Ma. - (2004).
Human mini-antibody cytotoxic for tumor cells which express the ErbB2 receptor
D'ALESSIO, GIUSEPPE;PICCOLI, RENATA;DE LORENZO, CLAUDIA;
2004
Abstract
The invention refers to a fully human miniantibody (scFv), called Erbicin, specific for the receptor ErbB2, with a pharmacological, in particular antitumour, activity. It has been obtained from a larger fagmidic library (Griffin 1.) of human synthetic scFv by panning (affinity selection on antigen) carried out on live cells that express various levels of ErbB2. The invention relates also to the DNA and amino acid sequences of said antibody, to the procedure for isolating it, to its use in therapy.File | Dimensione | Formato | |
---|---|---|---|
US7585952 B2.pdf
non disponibili
Tipologia:
Documento in Post-print
Licenza:
Accesso privato/ristretto
Dimensione
1.85 MB
Formato
Adobe PDF
|
1.85 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
US Filing Document.pdf
non disponibili
Tipologia:
Altro materiale allegato
Licenza:
Accesso privato/ristretto
Dimensione
137.03 kB
Formato
Adobe PDF
|
137.03 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Doc concessione.pdf
non disponibili
Tipologia:
Altro materiale allegato
Licenza:
Accesso privato/ristretto
Dimensione
159.46 kB
Formato
Adobe PDF
|
159.46 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.